KRAS and P53 Gene Mutation Patterns Linked to Colorectal Cancer in Sudan

Balgis Elhag Ibrahim Tager, Salah Eldin G. Elzaki, Ahmed Abdula Agabeldour, Hussain Gadelkarim Ahmed
{"title":"KRAS and P53 Gene Mutation Patterns Linked to Colorectal Cancer in Sudan","authors":"Balgis Elhag Ibrahim Tager, Salah Eldin G. Elzaki, Ahmed Abdula Agabeldour, Hussain Gadelkarim Ahmed","doi":"10.36348/sjm.2024.v09i02.004","DOIUrl":null,"url":null,"abstract":"Background: Molecular pathogenesis of CRC represents a major target for understanding and controlling of the disease in the Sudan. Therefore, the present study aimed to explore the clinicopathological pattern of CRC in the Sudan with specific emphases in the role KRAS and P53 genes mutations. Methodology: This study was carried out in El-Obeid, North Kordofan state, Sudan, using CRC samples from patients who presented to the Al-Obeid teaching hospital between 2017 and 2022 and had a biopsy for histopathological diagnosis. This series featured everyone who has CRC. Results: The most prevalent CRC subtype is adenocarcinoma, which is followed by mucinous adenocarcinoma and metastatic adenocarcinoma, which constitute 74%, 20%, and 6%, respectively. KRAS mutation was found in 40% patients 48% males and 33.3% females). P53 mutation was found in 46% individuals 43.5% men and 48% females. Positive correlations between KRAS and P53 were found in 26% cases, while negative correlations were found in 40% cases. Conclusion: Many CRC patients in Sudan present at advanced stages of the illness and at a younger age, necessitating early screening measures. CRC patients have been discovered to have KRAS, P53, or both mutations. As a result, precise preventative and therapeutic methods are considered essential.","PeriodicalId":510088,"journal":{"name":"Saudi Journal of Medicine","volume":"21 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/sjm.2024.v09i02.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Molecular pathogenesis of CRC represents a major target for understanding and controlling of the disease in the Sudan. Therefore, the present study aimed to explore the clinicopathological pattern of CRC in the Sudan with specific emphases in the role KRAS and P53 genes mutations. Methodology: This study was carried out in El-Obeid, North Kordofan state, Sudan, using CRC samples from patients who presented to the Al-Obeid teaching hospital between 2017 and 2022 and had a biopsy for histopathological diagnosis. This series featured everyone who has CRC. Results: The most prevalent CRC subtype is adenocarcinoma, which is followed by mucinous adenocarcinoma and metastatic adenocarcinoma, which constitute 74%, 20%, and 6%, respectively. KRAS mutation was found in 40% patients 48% males and 33.3% females). P53 mutation was found in 46% individuals 43.5% men and 48% females. Positive correlations between KRAS and P53 were found in 26% cases, while negative correlations were found in 40% cases. Conclusion: Many CRC patients in Sudan present at advanced stages of the illness and at a younger age, necessitating early screening measures. CRC patients have been discovered to have KRAS, P53, or both mutations. As a result, precise preventative and therapeutic methods are considered essential.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
苏丹与结直肠癌有关的 KRAS 和 P53 基因突变模式
背景:在苏丹,CRC 的分子发病机制是了解和控制该疾病的主要目标。因此,本研究旨在探讨苏丹 CRC 的临床病理模式,特别强调 KRAS 和 P53 基因突变的作用。研究方法:本研究在苏丹北科尔多凡州的奥贝德进行,使用的 CRC 样本来自 2017 年至 2022 年期间在奥贝德教学医院就诊并进行组织病理学诊断活检的患者。该系列研究以所有患有 CRC 的人为对象。结果:最常见的 CRC 亚型是腺癌,其次是粘液腺癌和转移性腺癌,分别占 74%、20% 和 6%。在 40% 的患者中发现了 KRAS 突变,男性占 48%,女性占 33.3%。)46%的患者(男性占 43.5%,女性占 48%)发现了 P53 突变。在 26% 的病例中发现 KRAS 和 P53 呈正相关,而在 40% 的病例中发现两者呈负相关。结论苏丹的许多 CRC 患者处于疾病晚期且年龄较小,因此有必要采取早期筛查措施。已发现的 CRC 患者有 KRAS、P53 或两种基因突变。因此,精确的预防和治疗方法至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Patterns and Influencing Factors of Organisms and Sensitivity in Sputum at Sylhet The Prevalence and Associated Risk Factors of Pressure Injury among Adults at King Saud Medical City, Riyadh Erectile Dysfunction in Adults: A Review of Neurological Causes and Risk Factor Analysis Procalcitonin-A Marker of Sepsis An Impactful Health Fair in a Semi-Urban Community: Awolowo Town Case Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1